Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Dysphagia: A Novel Risk Factor for Poor Outcomes Following Cardiovascular Procedures.

Journal of the American Heart Association·2026
Same author

Interpretable Multimodal AI to Predict the Presence of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Cardiac Sarcoidosis Patients.

Circulation. Arrhythmia and electrophysiology·2026
Same author

General-purpose large language models outperform specialized clinical AI tools on medical benchmarks.

Nature medicine·2026
Same author

Can Systemic Sarcoidosis and Genetic Cardiomyopathy Coexist?

JACC. Case reports·2026
Same author

CNS-Obsidian: A Neurosurgical Vision-Language Model Built From Scientific Publications.

Neurosurgery·2026

Related Experiment Video

Updated: Jun 17, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.1K

Using Machine Learning for Early Prediction of Cardiogenic Shock in Patients With Acute Heart Failure.

Faisal Rahman1, Noam Finkelstein2, Anton Alyakin3

  • 1Department of Cardiology, Baylor College of Medicine, Houston, Texas.

Journal of the Society for Cardiovascular Angiography & Interventions
|August 12, 2024
PubMed
Summary

This study developed an algorithm to identify patients at high risk of cardiogenic shock (CS) early. The model predicts CS risk days in advance, enabling timely clinical intervention for heart failure patients.

Keywords:
Acute decompensated heart failurecardiogenic shockmachine learningrisk prediction

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

1.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: Jun 17, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.1K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

1.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Services Research

Background:

  • Cardiogenic shock (CS) remains a significant cause of mortality in heart failure patients, with rates between 40-60% despite advancements.
  • Continuous monitoring and risk stratification are crucial for improving outcomes in acute decompensated heart failure.

Purpose of the Study:

  • To develop and validate a predictive algorithm for early identification of patients at high risk of developing cardiogenic shock.
  • To enable proactive clinical management and intervention for high-risk heart failure patients.

Main Methods:

  • Retrospective analysis of 24,461 patients with acute decompensated heart failure.
  • Logistic regression model utilizing vital signs, lab values, and medication data.
  • Validation of algorithm's predictive accuracy and actionability through cohort analysis.

Main Results:

  • The algorithm identified high-risk patients with a 10.2-fold higher prevalence of CS compared to low-risk patients.
  • High-risk designation occurred a median of 1.7 days prior to clinical CS diagnosis.
  • Actionability assessment indicated potential for intervention in 12% of true positive cases and identified other shock types in 44% of false positives.

Conclusions:

  • The developed risk model accurately predicts patients at higher risk for cardiogenic shock, allowing for timely clinical care adjustments.
  • The algorithm's predictive capability presents an opportunity for intervention within a CS management strategy to escalate care.